Brain Diseases

The grounding supports multiple etiologic contributors rather than a single cause. These include aging, genetic predisposition, chemically induced injury, host-pathogen interactions, and disruption of the microbiota-gut-brain axis. The literature also indicates that blood-brain barrier impairment and dysregulated neuroimmune signaling can be associated with neurological and pathological conditions.

The literature describes brain disease mechanisms in terms of altered neuronal plasticity, signal transduction, neuroimmunomodulation, and cytokine-related immune signaling. It also highlights the microbiota-gut-brain axis, through which the brain and gut communicate via the immune system, tryptophan metabolism, the vagus nerve, the enteric nervous system, and microbial metabolites. In addition, disruption of blood-brain barrier integrity and corticosteroid receptor imbalance are presented as mechanisms that can alter brain homeostasis and vulnerability to disease.

Older age is supported as a risk factor in the context of age-related brain disease. Genetic predisposition is also supported, particularly where dysregulated stress-response pathways increase vulnerability in genetically predisposed individuals. The literature further suggests that factors influencing microbiota composition and blood-brain barrier integrity may increase susceptibility, but it does not specify individual exposures beyond that.

The grounding does not support a single standard treatment for brain diseases as a category. It indicates that therapy is disease-specific and may include neuropharmacological approaches and brain stimulation in contexts where neuroplasticity is being therapeutically targeted. It also notes that management of certain brain-related toxicities, such as CAR-T-associated neurotoxicity, requires intensive monitoring and prompt supportive management, but no general class-wide standard of care is defined.